The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug

S Klein - The AAPS journal, 2010 - Springer
Simulation of gastrointestinal conditions is essential to adequately predict the in vivo
behavior of drug formulations. To reduce the size and number of human studies required to …

Solubility and dissolution profile assessment in drug discovery

K Sugano, A Okazaki, S Sugimoto… - Drug metabolism and …, 2007 - jstage.jst.go.jp
The purposes of the review are to: a) Provide a comprehensible introduction of the-state-
ofthe-art sciences of solubility and dissolution, b) introduce typical technologies to assess …

Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled …

N Shah, RM Iyer, HJ Mair, D Choi, H Tian… - Journal of …, 2013 - Elsevier
The present work deals with improving the solubility of vemurafenib, a practically insoluble
drug, by converting it into an amorphous-solid dispersion using a solventcontrolled …

Solid lipid excipients as matrix agents for sustained drug delivery

Y Rosiaux, V Jannin, S Hughes… - Excipient Applications in …, 2015 - Springer
Lipid excipients are attracting interest from drug developers due to their performance, ease
of use, versatility and their potential to generate intellectual property through innovation in …

In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan

M Rao, A Bajaj, I Khole, G Munjapara… - Journal of inclusion …, 2013 - Springer
Telmisartan (TEL) is a BCS Class II drug having dissolution rate limited bioavailability. The
aim of work was to enhance the solubility of TEL so that bioavailability problems are solved …

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with …

RW Busby, MM Kessler, WP Bartolini, AP Bryant… - … of Pharmacology and …, 2013 - ASPET
Linaclotide, a potent guanylate cyclase C agonist, is a therapeutic peptide approved in the
United States for the treatment of irritable bowel syndrome with constipation and chronic …

Dynamic Dissolution Testing To Establish In Vitro/In Vivo Correlations for Montelukast Sodium, a Poorly Soluble Drug

A Okumu, M DiMaso, R Löbenberg - Pharmaceutical research, 2008 - Springer
Purpose The objectives of the study was to develop a dissolution test method that can be
used to predict the oral absorption of montelukast sodium, and to establish an in vitro/in vivo …

Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption

N Kaur, A Narang, AK Bansal - European Journal of Pharmaceutics and …, 2018 - Elsevier
Compromised oral drug absorption, due to poor aqueous solubility, is one of the major
challenges faced by the pharmaceutical industry in the drug discovery and development …

A rational design of a biphasic dissolution setup—modelling of biorelevant kinetics for a ritonavir hot-melt extruded amorphous solid dispersion

A Denninger, U Westedt, J Rosenberg, KG Wagner - Pharmaceutics, 2020 - mdpi.com
Biphasic dissolution systems achieved good predictability for the in vivo performance of
several formulations of poorly water-soluble drugs by characterizing dissolution …

Process optimization of twin-screw melt granulation of fenofibrate using design of experiment (DoE)

HK Mamidi, S Palekar, PK Nukala, SM Mishra… - International Journal of …, 2021 - Elsevier
The purpose of this study was to optimize the melt granulation process of fenofibrate using
twin-screw granulator. Initial screening was performed to select the excipients required for …